Controlled releasing properties of gelatin nanofabric device containing chlorhexidine
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We aimed to evaluate the degradation and antimicrobial activity of novel chlorhexidine-containing gelatin nanofabric devices and their cytotoxicity in animals. The electro-spun device with a size of 3×4×0.4 mm3 was prepared by entrapping chlorhexidine gluconate (CHX) in a gelatin matrix. The devices were divided into three groups based on the CHX percentage (G1: 46%, G2: 50%, and G3: 54%), and the commercial product, PerioChip (CP), was used for the control group. We used an in vitro test for the degradation and antibacterial activity and investigated cytotoxicity using an in vivo test. Artificial saliva was used for the degradation test of chips and blood agar plates seeded with the oral bacteria Streptococcus sanguinis to address antibacterial activity. Furthermore, the devices were inserted between the skin and muscle of rat abdomens to evaluate infection and inflammatory reactions. We detected no obvious differences in the antibacterial or degradation test results between the test and control groups. In the histological analysis, the scaffold without CHX showed no signs of infection or inflammatory reaction. Both CHX-containing groups exhibited inflammation and necrosis in the muscle and skin, although the reaction in the test group was milder. In the degradation tests, antibacterial tests, and cytotoxic reactions in animal experiments, the electro-spun gelatin-based device showed similar results to those of the commercial device in the control group. Further studies on the quantitative analysis and clinical outcome evaluation of the electro-spun gelatin-based device in humans are necessary.
Abstract
We aimed to evaluate the degradation and antimicrobial activity of novel chlorhexidine-containing gelatin nanofabric devices and their cytotoxicity in animals. The electro-spun device with a size of 3×4×0.4 mm3 was prepared by entrapping chlorhexidine gluconate (CHX) in a gelatin matrix. The devices were divided into three groups based on the CHX percentage (G1: 46%, G2: 50%, and G3: 54%), and the commercial product, PerioChip (CP), was used for the control group. We used an in vitro test for the degradation and antibacterial activity and investigated cytotoxicity using an in vivo test. Artificial saliva was used for the degradation test of chips and blood agar plates seeded with the oral bacteria Streptococcus sanguinis to address antibacterial activity. Furthermore, the devices were inserted between the skin and muscle of rat abdomens to evaluate infection and inflammatory reactions. We detected no obvious differences in the antibacterial or degradation test results between the test and control groups. In the histological analysis, the scaffold without CHX showed no signs of infection or inflammatory reaction. Both CHX-containing groups exhibited inflammation and necrosis in the muscle and skin, although the reaction in the test group was milder. In the degradation tests, antibacterial tests, and cytotoxic reactions in animal experiments, the electro-spun gelatin-based device showed similar results to those of the commercial device in the control group. Further studies on the quantitative analysis and clinical outcome evaluation of the electro-spun gelatin-based device in humans are necessary.
참고문헌 (32)
- Marsh PD, "Host defenses and microbial homeostasis : role of microbial interactions", J Dent Res, 68, pp.1567~1575 (1989)
- Joerg Meyle, "Molecular aspects of the pathogenesis of periodontitis", Periodontology 2000, 69(1), pp.7~17 (2015), Wiley[DOI]
- A. D. Haffajee, "The effect of SRP on the clinical and microbiological parameters of periodontal diseases", Journal of Clinical Periodontology, 24(5), pp.324~334 (1997), Wiley[DOI]
- LJA Heitz-Mayfield, "Systemic antibiotics in periodontal therapy", Australian Dental Journal, 54(Suppl 1), pp.S96~S101 (2009), Wiley[DOI]
- Andrea Mombelli, "Topical and systemic antibiotics in the management of periodontal diseases", International Dental Journal, 54(1), pp.3~14 (2004), Elsevier BV[DOI]
- Abdul Ahad, "Effect of Antimicrobial Photodynamic Therapy as an Adjunct to Nonsurgical Treatment of Deep Periodontal Pockets: A Clinical Study", Journal of Lasers in Medical Sciences, 7(4), pp.220~226 (2016), Maad Rayan Publishing Company[DOI]
- C. M. Ardila, "Antibiotic resistance of subgingival species in chronic periodontitis patients", Journal of Periodontal Research, 45, pp.557~563 (2010), Wiley[DOI]
- Goodson JM, "Clinical responses following periodontal treatment by local drug delivery", J Periodontol, 56(Suppl 11S), pp.81~87 (1985)[DOI]
- Garg S, "Local drug delivery systems as an adjunct to cure periodontitis-the novel dental applicant", Pharm Methods, 6, pp.1~8 (2015)
- Rajeshwari H.R., "Local drug delivery systems in the management of periodontitis: A scientific review", Journal of Controlled Release, 307, pp.393~409 (2019), Elsevier BV[DOI]
- Kaplish V, "Local drug delivery systems in the treatment of periodontitis : a review", Pharmacophore, 4, pp.39~49 (2013)
- Won-Youl Choi, "Improved osseointegration of dental titanium implants by TiO2 nanotube arrays with recombinant human bone morphogenetic protein-2: a pilot in vivo study", International Journal of Nanomedicine, 10, pp.1145~1154 (2015), Informa UK Limited[DOI]
- Somayeh Hallaj Nezhadi, "Gelatin-based delivery systems for cancer gene therapy", Journal of Drug Targeting, 17(10), pp.731~738 (2009), Informa UK Limited[DOI]
- D Olsen, "Recombinant collagen and gelatin for drug delivery", Advanced Drug Delivery Reviews, 55(12), pp.1547~1567 (2003), Elsevier BV[DOI]
- Ahmed O. Elzoghby, "Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research", Journal of Controlled Release, 172(3), pp.1075~1091 (2013), Elsevier BV[DOI]
- K Karthikeyan, "Formulation of Bioadhesive Carbomer Gel Incorporating Drug-Loaded Gelatin Microspheres for Periodontal Therapy", Tropical Journal of Pharmaceutical Research, 11(3), pp.335~343 (2012), African Journals Online (AJOL)[DOI]
- K. Madhumathi, "Tailoring antibiotic release for the treatment of periodontal infrabony defects using bioactive gelatin-alginate", apatite nanocomposite films, 2018, pp.43, 57~64[DOI]
- Kothari S, "Periodontal chip: an adjunct to conventional surgical treatment", Int Drug Res Tech, 2, pp.411~421 (2012)
- Agneta Rosengren, "Comparison of implantation and cytotoxicity testing for initially toxic biomaterials", Journal of Biomedical Materials Research Part A, 75A(1), pp.115~122 (2005), Wiley[DOI]
- D. Steinberg, "A New Degradable Controlled Release Device for Treatment of Periodontal Disease: In Vitro Release Study", Journal of Periodontology, 61(7), pp.393~398 (1990), Wiley[DOI]
- L. G. Hjeljord, "Chlorhexidine-protein interactions", Journal of Periodontal Research, 8(s12), pp.11~16 (1973), Wiley[DOI]
- Marie Westling, "Microbiological and clinical short-term effects of repeated intracrevicular chlorhexidine rinsings", Journal of Periodontal Research, 19(2), pp.202~209 (1984), Wiley[DOI]
- Aubrey Soskolne, "New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy", J Periodontal Res, 18(3), pp.330~336 (1983), Wiley[DOI]
- Ayala Stabholz, "Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets", Journal of Clinical Periodontology, 13(8), pp.783~788 (1986), Wiley[DOI]
- W.A. Soskolne, "Sustained Local Delivery of Chlorhexidine in the Treatment of Periodontitis: A Multi-Center Study", Journal of Periodontology, 68(1), pp.32~38 (1997), Wiley[DOI]
- Marjorie K. Jeffcoat, "Adjunctive Use of a Subgingival Controlled-Release Chlorhexidine Chip Reduces Probing Depth and Improves Attachment Level Compared With Scaling and Root Planing Alone", Journal of Periodontology, 69(9), pp.989~997 (1998), Wiley[DOI]
- S. Pattnaik, "Clinical and antimicrobial efficacy of a controlled-release device containing chlorhexidine in the treatment of chronic periodontitis", European Journal of Clinical Microbiology & Infectious Diseases, 34(10), pp.2103~2110 (2015), Springer Science and Business Media LLC[DOI]
- Charles L. Berman, "The Chlorhexidine Question", Journal of Periodontology, 55(11), pp.668~669 (1984), Wiley[DOI]
- Banting D, "Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years", J Dent Res, 68, pp.1716~1718 (1989)
- Brien V. Harvey, "Effects of Chlorhexidine on the Structure and Permeability of Hamster Cheek Pouch Mucosa", Journal of Periodontology, 55(10), pp.608~614 (1984), Wiley[DOI]
- Fiorentino M, "Analytical methods for the determination of chlorhexidine : a review", Crit Rev Anal Chem, 40, pp.89~101 (2010)
- A. Stanley, "The in vitro effects of chlorhexidine on subgingival plaque bacteria", Journal of Clinical Periodontology, 16(4), pp.259~264 (1989), Wiley[DOI]